News Release AstraZeneca Out-licenses Imaging Agent for Amyloid Detection to Aid Diagnosis of Alzheimer’s Disease to Neoprobe 13 December, 2011 – AstraZeneca today announced it has out-licensed AZD4694, its late-sta - Release agent - Document - PDFSEARCH.IO

First Page	Meta Content
	News Release AstraZeneca Out-licenses Imaging Agent for Amyloid Detection to Aid Diagnosis of Alzheimer’s Disease to Neoprobe 13 December, 2011 – AstraZeneca today announced it has out-licensed AZD4694, its late-sta Add to Reading List Open Document File Size: 218,92 KB Share Result on Facebook

News Release AstraZeneca Out-licenses Imaging Agent for Amyloid Detection to Aid Diagnosis of Alzheimer’s Disease to Neoprobe 13 December, 2011 – AstraZeneca today announced it has out-licensed AZD4694, its late-staAdd to Reading List